Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00411788
Status:
COMPLETED
Last Update Posted:
2016-09-21
First Post:
2006-12-14
Brief Title:
A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
Sponsor:
Yale University
Organization:
Yale University
Organization Data
Organization:
Yale University
Class:
OTHER
Study ID:
0605001396
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Yale University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |